<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01417117</url>
  </required_header>
  <id_info>
    <org_study_id>11011402</org_study_id>
    <nct_id>NCT01417117</nct_id>
  </id_info>
  <brief_title>Effect of Ischemic Strokes on Recovery From Intracerebral Hemorrhages</brief_title>
  <official_title>The Effect of Diffusion Weighted Imaging Abnormalities on Outcomes in Patients With Spontaneous Intracerebral Hemorrhage</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Rush University Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>American Heart Association</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Rush University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Rush University Medical Center</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Intracerebral hemorrhage (ICH) occurs when small arteries in the brain rupture due to&#xD;
      weakening by age, high blood pressure, and/or elevated cholesterol. In addition to artery&#xD;
      rupture, recent data suggests that patients with ICH are also at risk for developing&#xD;
      occlusion of arteries during the acute phase, called ischemic strokes. Data suggests these&#xD;
      ischemic strokes can negatively impact patient outcomes. Diffusion weighted imaging (DWI) is&#xD;
      a sequence on Magnetic Resonance Imaging (MRI) that is a sensitive marker for ischemic&#xD;
      strokes in the brain. In this proposal, our primary aim is examine prospectively the effect&#xD;
      DWI abnormalities have on functional outcomes in patients with ICH. Our hypothesis is that&#xD;
      the DWI abnormalities found on MRI of the brain lead to worse functional outcomes in patients&#xD;
      with ICH&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Diffusion weighted imaging (DWI) is a sensitive method to assess for secondary ischemia in&#xD;
      patients with acute brain injury. By comparing the outcomes of patients with and without DWI&#xD;
      abnormalities, we would able to assess the impact these lesions have on functional recovery&#xD;
      in patients with ICH. Since no direct therapies exist for this disease, DWI abnormalities may&#xD;
      be a novel target for intervention to improve outcomes. If traditionally assessed functional&#xD;
      outcomes are not affected by DWI, the mechanism behind these lesions would still warrant&#xD;
      further evaluation and potential treatment. Detection of subclinical infarcts has emerged as&#xD;
      a potential surrogate marker for subsequent risk of stroke, vascular dementia, and cognitive&#xD;
      impairment. Furthermore, the cause behind DWI lesions in acute ICH may lead to better&#xD;
      understanding the pathophysiologic interplay between ischemic and hemorrhagic strokes.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">September 2011</start_date>
  <completion_date type="Actual">June 2017</completion_date>
  <primary_completion_date type="Actual">June 2017</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Modified Rankin Scale (mRS)</measure>
    <time_frame>3 months</time_frame>
    <description>Modified Rankin Scale (mRS)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>National Institutes of Health Stroke Scale</measure>
    <time_frame>14 days or discharge</time_frame>
    <description>National Institutes of Health Stroke Scale</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Modified Rankin Scale (mRS)</measure>
    <time_frame>14 days</time_frame>
    <description>Modified Rankin Scale (mRS)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Modified Rankin Scale (mRS)</measure>
    <time_frame>6 months</time_frame>
    <description>Modified Rankin Scale (mRS)</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">130</enrollment>
  <condition>Hemorrhage; Intracerebral, Nontraumatic</condition>
  <condition>Ischemic Strokes</condition>
  <condition>Diffusion Weighted Imaging Lesions</condition>
  <arm_group>
    <arm_group_label>Spontaneous Intracerebral Hemorrhage</arm_group_label>
    <description>Patients with primary intracerebral hemorrhage within 24 hours of admission diagnosed by non-contrast head computed tomography (CT)</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Subjects for this study will be selected from patients admitted with a primary&#xD;
        intracerebral hemorrhage to Rush University Medical Center's Neurosciences Intensive Care&#xD;
        Unit.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patients &gt; 18 years and &lt; 80 years&#xD;
&#xD;
          -  Spontaneous intracerebral hemorrhage documented by CT scan&#xD;
&#xD;
          -  Less than 24 hours from time last seen normal to first medical evaluation&#xD;
&#xD;
          -  No prior clinical history of stroke (i.e. subarachnoid hemorrhage, ICH, or ischemic&#xD;
             strokes)&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Pregnancy&#xD;
&#xD;
          -  History of cancer&#xD;
&#xD;
          -  Pre-admission mRS &gt; 2&#xD;
&#xD;
          -  Glasgow Coma Scale less than 5&#xD;
&#xD;
          -  ICH secondary to aneurysm, vascular malformation, mycotic aneurysm, primary or&#xD;
             metastatic tumor, trauma, warfarin-related ICH, acute-fibrinolytic associated ICH, or&#xD;
             coagulopathy&#xD;
&#xD;
          -  Associated epidural or subdural hematoma&#xD;
&#xD;
          -  Surgical intervention &lt; 48 hours from admission&#xD;
&#xD;
          -  Hemodynamic instability (need for vasopressor therapy)&#xD;
&#xD;
          -  Acute hypoxemic or hypercapnic respiratory failure&#xD;
&#xD;
          -  History of deep venous thrombosis&#xD;
&#xD;
          -  Contraindications to MRI based upon institutional safety checklist&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>19 Years</minimum_age>
    <maximum_age>79 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Rajeev K Garg, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Rush University Medical Center Deparment of Neurological Sciences</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Rush University Medical Center</name>
      <address>
        <city>Chicago</city>
        <state>Illinois</state>
        <zip>60612</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>October 2017</verification_date>
  <study_first_submitted>August 12, 2011</study_first_submitted>
  <study_first_submitted_qc>August 15, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 16, 2011</study_first_posted>
  <last_update_submitted>October 18, 2017</last_update_submitted>
  <last_update_submitted_qc>October 18, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">October 20, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Rush University Medical Center</investigator_affiliation>
    <investigator_full_name>Rajeev K Garg</investigator_full_name>
    <investigator_title>Assistant Professor of Neurological Sciences and Neurosurgery</investigator_title>
  </responsible_party>
  <keyword>Intracerebral Hemorrhage</keyword>
  <keyword>Ischemic Stroke</keyword>
  <keyword>Diffusion Weight Imaging Abnormalities</keyword>
  <keyword>Neurologic Outcome</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Stroke</mesh_term>
    <mesh_term>Ischemic Stroke</mesh_term>
    <mesh_term>Cerebral Hemorrhage</mesh_term>
    <mesh_term>Ischemia</mesh_term>
    <mesh_term>Hemorrhage</mesh_term>
    <mesh_term>Body Weight</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

